Business
Vaccine Manufacturer Janssen to Shutter Bern Plant by End of 2026
Johnson & Johnson subsidiary Janssen confirms it will close its vaccine development plant in Bern-Bümpliz in stages, with a full closure by the end of 2026. The move affects approximately 300 employees, for whom a social plan has been negotiated.
8 months ago · 1 source
